Initial Statement of Beneficial Ownership (3)
January 11 2021 - 4:41PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
COWARD D SCOTT |
2. Date of Event Requiring Statement (MM/DD/YYYY)
12/30/2020
|
3. Issuer Name and Ticker or Trading Symbol
EXACT SCIENCES CORP [EXAS]
|
(Last)
(First)
(Middle)
C/O EXACT SCIENCES CORP., 5505 ENDEAVOR LANE |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner ___X___ Officer (give title below) _____ Other (specify below) Chief Administrative Officer / |
(Street)
MADISON, WI 53719
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 1301 | D | |
Common Stock | 4073 | I | Held in 401(k) Plan |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Restricted Stock Units | (1) | (1) | Common Stock | 12850 | (2) | D | |
Restricted Stock Units | (3) | (3) | Common Stock | 10050 | (2) | D | |
Restricted Stock Units | (4) | (4) | Common Stock | 9789 | (2) | D | |
Restricted Stock Units | (5) | (5) | Common Stock | 15888 | (2) | D | |
Stock Option (right to buy) | (6) | (6) | Common Stock | 18750 | $21.68 | D | |
Stock Option (right to buy) | (7) | (7) | Common Stock | 8350 | $44.37 | D | |
Stock Option (right to buy) | (8) | (8) | Common Stock | 8090 | $92.62 | D | |
Stock Option (right to buy) | (9) | (9) | Common Stock | 12875 | $98.18 | D | |
Explanation of Responses: |
(1) | Represents a restricted stock unit award that vests in full on February 23, 2021. |
(2) | Each restricted stock unit represents a contingent right to receive one share of common stock. |
(3) | Represents a restricted stock unit award that vests in two equal annual installments beginning on February 27, 2021. |
(4) | Represents a restricted stock unit award that vests in three equal annual installments beginning on February 26, 2021. |
(5) | Represents a restricted stock unit award that vests in four equal annual installments beginning on February 14, 2021. |
(6) | These options vest and become exercisable in full on February 23, 2021. |
(7) | These options vest and become exercisable in two equal annual installments beginning on February 27, 2021. |
(8) | These options vest and become exercisable in three equal annual installments beginning on February 26, 2021. |
(9) | These options vest and become exercisable in four equal annual installments beginning on February 14, 2021. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
COWARD D SCOTT C/O EXACT SCIENCES CORP. 5505 ENDEAVOR LANE MADISON, WI 53719 |
|
| Chief Administrative Officer |
|
Signatures
|
/s/ D. Scott Coward by Mark R. Busch, attorney-in-fact | | 1/11/2021 |
**Signature of Reporting Person | Date |
EXACT Sciences (NASDAQ:EXAS)
Historical Stock Chart
From Mar 2024 to Apr 2024
EXACT Sciences (NASDAQ:EXAS)
Historical Stock Chart
From Apr 2023 to Apr 2024